featured
Incidence and Progression of Diabetic Retinopathy in Patients Treated With GLP-1 Receptor Agonists vs SGLT2 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Incidence and progression of diabetic retinopathy in patients treated with glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: A population-based cohort study
Diabetes Obes Metab 2024 Jul 19;[EPub Ahead of Print], DS Lin, HY Lo, KC Huang, TT Lin, JK Lee, LY LinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.